Purigen Biosystems is redefining nucleic acid sample prep by providing an innovative platform based on the remarkably efficient isotachophoresis technology invented in the lab of Stanford University professor Juan Santiago. Purigen's automated benchtop instrumentation and accompanying microfluidic chip purifies and quantitates nucleic samples from a wide variety of sources, including minute or otherwise challenging cancer samples. The purified DNA or RNA is then immediately compatible with a wide range of downstream detection methods, including next generation sequencing, PCR, and other genomic tests.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
05/18/16	$18,200,000	Series A	5AM Ventures Roche Venture Fund Stanford-StartX Fund Western Investments Capital	undisclosed
06/12/19	$26,400,000	Series B	5AM Ventures Agilent Technologies Cota Capital Roche Venture Fund	undisclosed